Press Releases

Date	Title and Summary	Additional Formats
June 28, 2005	Aastrom Biosciences, Inc. Added to Russell 3000 Index	View HTML Aastrom Biosciences, Inc. Added to Russell 3000 Index
June 22, 2005	Timothy M. Mayleben Elected to Aastrom Biosciences' Board of Directors	View HTML Timothy M. Mayleben Elected to Aastrom Biosciences' Board of Directors
June 20, 2005	Aastrom Biosciences Appoints New Chief Financial Officer	View HTML Aastrom Biosciences Appoints New Chief Financial Officer
June 10, 2005	Aastrom Biosciences' CEO to Present at the Morgan Stanley Small Cap Executive Conference	View HTML Aastrom Biosciences' CEO to Present at the Morgan Stanley Small Cap Executive Conference
May 17, 2005	Aastrom Biosciences Reports Positive Bone Repair Results in Clinical Feasibility Trial	View HTML Aastrom Biosciences Reports Positive Bone Repair Results in Clinical Feasibility Trial
May 6, 2005	Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2005 Financial Results	View HTML Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2005 Financial Results
May 5, 2005	Aastrom Biosciences to Hold Investor Conference Call Tomorrow	View HTML Aastrom Biosciences to Hold Investor Conference Call Tomorrow
May 3, 2005	Aastrom Biosciences to Hold Investor Conference Call	View HTML Aastrom Biosciences to Hold Investor Conference Call
April 29, 2005	Aastrom Biosciences' CEO to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	View HTML Aastrom Biosciences' CEO to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference
April 26, 2005	Aastrom Biosciences Issues Statement on Unique Features of Its Bone Marrow Tissue Repair Cell Product and Technology	View HTML Aastrom Biosciences Issues Statement on Unique Features of Its Bone Marrow Tissue Repair Cell Product and Technology

Investor Relations

Press Releases

Company Presentation